Skip to content

Net Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
Merck & Co. logo
Merck & Co.MRK
-$4.24B-183%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$632.78M-388%
UroGen Pharma logo
UroGen PharmaURGN
-$23.57M+46.2%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-$98.54M-36.5%
CG Oncology logo
CG OncologyCGON
-$60.2M-74.7%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s net income?
Aura Biosciences, Inc. (AURA) reported net income of -$33.69M in Q1 2026.
How has Aura Biosciences, Inc.'s net income changed year-over-year?
Aura Biosciences, Inc.'s net income decreased by 22.6% year-over-year, from -$27.48M to -$33.69M.
What is the long-term trend for Aura Biosciences, Inc.'s net income?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s net income has grown at a 31.7% compound annual growth rate (CAGR), from -$35.25M to -$106.19M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.